The role of extracellular vesicles in modulating neuronal excitability and function in aging and alzheimer's disease

Active Grant Awarded

Award ID
FAG106823U1QMM3
Recipient
Awarding agency
Obligated
$81,280

Award facts

Assistance listing
93.AG4 National Institute on Aging Training Individual Projects
Completion date 0% complete
Place of performance
Jacksonville, FL 32224, USA

Award details come from USAspending.gov.

Description

Abstract
To develop targeted therapeutics for alzheimer's disease (ad), we must first understand the molecular mechanisms underlying neuronal dysfunction throughout the disease course. Neuroimaging studies demonstrated that the excitability of neurons is correlated with disease progression, suggesting the close correlation of ad pathology and altered neuronal excitability. These changes in excitability disrupt the network function in critical circuits, ultimately leading to memory deficits that are a hallmark of ad. Despite this, the molecular mechanisms behind excitability dysfunction and the spread of ad pathology through neuronal populations are not well understood. Evidence has shown that extracellular vesicles (EVS) from the surrounding microenvironment can spread key bioactive molecules throughout neural circuitry in ad, with my preliminary voltage-clamp data even showing that these EVS can also alter the function of voltage-gated ION channels. However, the impact of EVS on the biophysical properties and protein expression of different neuronal populations remains largely unexplored. Here, I hypothesize that 1) EVS can regulate neurophysiology, which is compromised in ad-related disease conditions. 2) the neurophysiological effects of EVS are mediated through modulation of voltage-gated sodium (NAV) and potassium (KV) channels in both excitatory and inhibitory neurons, and restoring EV-mediated regulation of these channels may help recover normal neuronal function in ad. In this project, I aim to address the following questions 1) how do EVS derived from various stages of healthy aging and ad influence voltage-gated ION channel function across different neuronal populations? 2) which cell-type-specific contributions and EV-associated molecules drive these changes? To address these questions, the proposed study will develop and implement an integrative 'patch- proteomics' approach that combines state-of-the-art electrophysiological and proteomic techniques on human induced pluripotent stem cell (HIPSC) derived glutaminergic and gabaergic neurons. Leveraging the mayo clinic brain and ipsc bank, I will also isolate EVS from a diversity of healthy and ad microenvironmental contexts. These proposed studies will provide novel insights into EV interactions with target neurons in both aging and ad pathology, potentially uncovering novel therapeutic targets. This project will be conducted jointly in the laboratories of DR. Ikezu and DR. Rossoll at mayo clinic florida, providing a collaborative and multidisciplinary training environment. I will receive top-tier, hands-on instruction in cutting-edge techniques spanning EV biology, electrophysiology, computational modeling, and precision proteomics. The combined expertise and resources of both labs support advanced EV, ipsc, and proteomic work, with strong opportunities for training and dissemination through mayo clinic programs. Importantly, this study may reveal novel ad therapeutic targets and lay the foundation for understanding EV-driven neuronal vulnerability.

Quick answers

Who received award FAG106823U1QMM3?

FAG106823U1QMM3 was awarded to Mayo Clinic Jacksonville (A Nonprofit Corporation) by National Institute on Aging (National Institutes of Health) on November 16, 2026.

How much is award FAG106823U1QMM3 worth?

$81,280 has been obligated on FAG106823U1QMM3.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award